Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	KIF1A ABCA13 MYO10 MYH7B KIF1B ABCC9 MYO1B BTAF1 XRCC2 ABCA10 ZRANB3 ABCC12 ACSM2A DYNC1H1 ACSM2B	4.52e-05	614	146	15	GO:0140657
GeneOntologyMolecularFunction	transporter activity	CACNA1B TRPM4 MRS2 ABCA13 SLC35C1 GRAMD1A HCN3 ABCC9 SPNS3 PKD1L2 PKDREJ SLC1A3 ABCA10 CLCC1 C2CD2L GJB5 LRP2 LRP6 ABCC12 SLC49A3 SLC25A28 NALF2 CNGA4	6.14e-05	1289	146	23	GO:0005215
GeneOntologyMolecularFunction	benzoate-CoA ligase activity	ACSM2A ACSM2B	1.59e-04	3	146	2	GO:0018858
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	LRP1 LRP2 LRP6	2.00e-04	16	146	3	GO:0005041
GeneOntologyMolecularFunction	cytoskeletal motor activity	KIF1A MYO10 MYH7B KIF1B MYO1B DYNC1H1	2.32e-04	118	146	6	GO:0003774
GeneOntologyMolecularFunction	decanoate-CoA ligase activity	ACSM2A ACSM2B	3.16e-04	4	146	2	GO:0102391
GeneOntologyMolecularFunction	calcium channel activity	CACNA1B TRPM4 PKD1L2 PKDREJ NALF2 CNGA4	3.75e-04	129	146	6	GO:0005262
GeneOntologyMolecularFunction	transmembrane transporter activity	CACNA1B TRPM4 MRS2 ABCA13 SLC35C1 HCN3 ABCC9 SPNS3 PKD1L2 PKDREJ SLC1A3 ABCA10 CLCC1 GJB5 LRP6 ABCC12 SLC49A3 SLC25A28 NALF2 CNGA4	3.80e-04	1180	146	20	GO:0022857
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA13 ABCC9 ABCA10 ABCC12	4.50e-04	49	146	4	GO:0140359
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	LRP1 LRP2 LRP6	4.62e-04	21	146	3	GO:0030228
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	CACNA1B TRPM4 MRS2 HCN3 ABCC9 PKD1L2 PKDREJ SLC1A3 SLC25A28 NALF2 CNGA4	6.33e-04	465	146	11	GO:0046873
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	CACNA1B TRPM4 PKD1L2 PKDREJ NALF2 CNGA4	8.61e-04	151	146	6	GO:0015085
GeneOntologyCellularComponent	axon	CACNA1B DRD5 COPA KIF1A POLG KIF1B HCN3 ADGRL1 CBARP SYDE1 MAPK8IP3 GDPD5 ADRA2A DST LRP1 LRP2 PLEC DYNC1H1 HTT	1.62e-05	891	147	19	GO:0030424
GeneOntologyCellularComponent	axon cytoplasm	KIF1A KIF1B MAPK8IP3 DST DYNC1H1	1.17e-04	68	147	5	GO:1904115
GeneOntologyCellularComponent	neuron projection cytoplasm	KIF1A KIF1B MAPK8IP3 DST DYNC1H1 HTT	1.28e-04	110	147	6	GO:0120111
GeneOntologyCellularComponent	somatodendritic compartment	CACNA1B TRPM4 DRD5 HTR5A COPA KIF1A MYO10 KIF1B HCN3 ADGRB1 SLC1A3 MAPK8IP3 GDPD5 ADRA2A LRP1 LRP2 LRP6 PLEC CNGA4 DYNC1H1 HTT	1.40e-04	1228	147	21	GO:0036477
GeneOntologyCellularComponent	distal axon	CACNA1B COPA POLG HCN3 ADGRL1 CBARP MAPK8IP3 GDPD5 ADRA2A LRP1 LRP2	2.62e-04	435	147	11	GO:0150034
GeneOntologyCellularComponent	neuronal cell body	CACNA1B TRPM4 DRD5 HTR5A COPA KIF1A MYO10 HCN3 SLC1A3 GDPD5 ADRA2A LRP1 LRP6 CNGA4 DYNC1H1 HTT	2.68e-04	835	147	16	GO:0043025
GeneOntologyCellularComponent	cell body	CACNA1B TRPM4 DRD5 HTR5A COPA KIF1A MYO10 HCN3 SLC1A3 MAPK8IP3 GDPD5 ADRA2A LRP1 LRP6 CNGA4 DYNC1H1 HTT	2.93e-04	929	147	17	GO:0044297
GeneOntologyCellularComponent	apolipoprotein B mRNA editing enzyme complex	APOBEC3G APOBEC3F	4.84e-04	5	147	2	GO:0030895
GeneOntologyCellularComponent	endocytic vesicle membrane	ENTPD7 TBC1D5 RAPGEF1 KIAA0319 AP2A1 LRP1 LRP2	7.68e-04	212	147	7	GO:0030666
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	ENTPD7 COPA KIF1A ABCA13 SEC24A TBC1D5 KIF1B RAPGEF1 MYO1B CBARP KIAA0319 AP2A1 CLVS2 LRP1 LRP2 LRP6 TMEM163 CNGA4 RAB6A HTT	8.46e-04	1307	147	20	GO:0030659
GeneOntologyCellularComponent	membrane coat	COPA SEC24A TBC1D5 AP2A1 AP5Z1	9.21e-04	106	147	5	GO:0030117
GeneOntologyCellularComponent	coated membrane	COPA SEC24A TBC1D5 AP2A1 AP5Z1	9.21e-04	106	147	5	GO:0048475
GeneOntologyCellularComponent	vesicle membrane	ENTPD7 COPA KIF1A ABCA13 SEC24A TBC1D5 KIF1B RAPGEF1 MYO1B CBARP KIAA0319 AP2A1 CLVS2 LRP1 LRP2 LRP6 TMEM163 CNGA4 RAB6A HTT	1.00e-03	1325	147	20	GO:0012506
GeneOntologyCellularComponent	mRNA editing complex	APOBEC3G APOBEC3F	1.01e-03	7	147	2	GO:0045293
GeneOntologyCellularComponent	coated vesicle	COPA SEC24A TBC1D5 KIAA0319 AP2A1 CLVS2 LRP1 LRP2 HTT	1.03e-03	360	147	9	GO:0030135
GeneOntologyCellularComponent	vesicle coat	COPA SEC24A TBC1D5 AP2A1	1.28e-03	67	147	4	GO:0030120
GeneOntologyCellularComponent	clathrin-coated vesicle	TBC1D5 KIAA0319 AP2A1 CLVS2 LRP1 LRP2 HTT	1.46e-03	237	147	7	GO:0030136
GeneOntologyCellularComponent	growth cone	COPA ADGRL1 CBARP MAPK8IP3 GDPD5 LRP1 LRP2	1.77e-03	245	147	7	GO:0030426
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	KIF1A KIF1B MAPK8IP3 CFAP54 DST DYNC1H1 HTT BRWD1	1.85e-03	317	147	8	GO:0032838
GeneOntologyCellularComponent	site of polarized growth	COPA ADGRL1 CBARP MAPK8IP3 GDPD5 LRP1 LRP2	2.12e-03	253	147	7	GO:0030427
GeneOntologyCellularComponent	clathrin-coated endocytic vesicle membrane	TBC1D5 KIAA0319 AP2A1 LRP2	2.34e-03	79	147	4	GO:0030669
GeneOntologyCellularComponent	clathrin-coated pit	TBC1D5 AP2A1 LRP1 LRP2	2.45e-03	80	147	4	GO:0005905
GeneOntologyCellularComponent	hemidesmosome	DST PLEC	2.59e-03	11	147	2	GO:0030056
MousePheno	axonal spheroids	EPG5 DST TECPR2 AP5Z1	1.09e-05	17	119	4	MP:0010047
Domain	6-blade_b-propeller_TolB-like	APMAP NHLRC3 TECPR2 LRP1 LRP2 LRP6	1.43e-06	46	145	6	IPR011042
Domain	-	EVPL DST PLEC	9.01e-06	6	145	3	3.90.1290.10
Domain	PKD/REJ-like	PKD1L2 PKDREJ KIAA0319	9.01e-06	6	145	3	IPR002859
Domain	REJ	PKD1L2 PKDREJ KIAA0319	9.01e-06	6	145	3	PF02010
Domain	-	APMAP NHLRC3 LRP1 LRP2 LRP6	1.23e-05	39	145	5	2.120.10.30
Domain	APC_su10/DOC_dom	HECTD3 CUL9 ZZEF1	1.57e-05	7	145	3	IPR004939
Domain	Plectin	EVPL DST PLEC	1.57e-05	7	145	3	PF00681
Domain	DOC	HECTD3 CUL9 ZZEF1	1.57e-05	7	145	3	PS51284
Domain	ANAPC10	HECTD3 CUL9 ZZEF1	1.57e-05	7	145	3	PF03256
Domain	Plectin_repeat	EVPL DST PLEC	1.57e-05	7	145	3	IPR001101
Domain	APC10	HECTD3 CUL9 ZZEF1	1.57e-05	7	145	3	SM01337
Domain	PLEC	EVPL DST PLEC	1.57e-05	7	145	3	SM00250
Domain	GPS	ADGRB1 ADGRL1 PKD1L2 PKDREJ	1.35e-04	34	145	4	SM00303
Domain	Ldl_recept_b	LRP1 LRP2 LRP6	1.57e-04	14	145	3	PF00058
Domain	LDLRB	LRP1 LRP2 LRP6	1.57e-04	14	145	3	PS51120
Domain	GPS	ADGRB1 ADGRL1 PKD1L2 PKDREJ	1.89e-04	37	145	4	IPR000203
Domain	LY	LRP1 LRP2 LRP6	1.95e-04	15	145	3	SM00135
Domain	LDLR_classB_rpt	LRP1 LRP2 LRP6	1.95e-04	15	145	3	IPR000033
Domain	ARM-like	NCAPD3 PKP4 CUL9 BTAF1 KATNBL1 HEATR6 AP2A1 AP5Z1 HTT	2.64e-04	270	145	9	IPR011989
Domain	P-loop_NTPase	KIF1A ABCA13 MYO10 MYH7B KIF1B NDST4 ABCC9 MYO1B BTAF1 XRCC2 RAB6B ABCA10 ZRANB3 LRRIQ1 ABCC12 RAB6A DYNC1H1	3.17e-04	848	145	17	IPR027417
Domain	-	NCAPD3 PKP4 CUL9 BTAF1 HEATR6 AP2A1 AP5Z1 HTT	3.47e-04	222	145	8	1.25.10.10
Domain	Kinesin-like_KIF1-typ	KIF1A KIF1B	3.56e-04	4	145	2	IPR022140
Domain	KIF1B	KIF1A KIF1B	3.56e-04	4	145	2	PF12423
Domain	REJ	PKD1L2 PKDREJ	3.56e-04	4	145	2	PS51111
Domain	REJ_dom	PKD1L2 PKDREJ	3.56e-04	4	145	2	IPR014010
Domain	Ldl_recept_a	TMPRSS9 LRP1 LRP2 LRP6	4.06e-04	45	145	4	PF00057
Domain	-	TMPRSS9 LRP1 LRP2 LRP6	4.41e-04	46	145	4	4.10.400.10
Domain	LDLRA_1	TMPRSS9 LRP1 LRP2 LRP6	5.20e-04	48	145	4	PS01209
Domain	ABC_tran	ABCA13 ABCC9 ABCA10 ABCC12	5.20e-04	48	145	4	PF00005
Domain	ABC_TRANSPORTER_2	ABCA13 ABCC9 ABCA10 ABCC12	5.20e-04	48	145	4	PS50893
Domain	LDrepeatLR_classA_rpt	TMPRSS9 LRP1 LRP2 LRP6	5.63e-04	49	145	4	IPR002172
Domain	LDLa	TMPRSS9 LRP1 LRP2 LRP6	5.63e-04	49	145	4	SM00192
Domain	ABC_TRANSPORTER_1	ABCA13 ABCC9 ABCA10 ABCC12	5.63e-04	49	145	4	PS00211
Domain	LDLRA_2	TMPRSS9 LRP1 LRP2 LRP6	5.63e-04	49	145	4	PS50068
Domain	Gal_Lectin	ADGRL1 PKD1L2	5.89e-04	5	145	2	PF02140
Domain	PKD_2	PKD1L2 PKDREJ	5.89e-04	5	145	2	IPR003915
Domain	Lectin_gal-bd_dom	ADGRL1 PKD1L2	5.89e-04	5	145	2	IPR000922
Domain	SUEL_LECTIN	ADGRL1 PKD1L2	5.89e-04	5	145	2	PS50228
Domain	ABC_transporter-like	ABCA13 ABCC9 ABCA10 ABCC12	6.08e-04	50	145	4	IPR003439
Domain	Kinesin_assoc	KIF1A KIF1B	8.80e-04	6	145	2	PF16183
Domain	Kinesin-like	KIF1A KIF1B	8.80e-04	6	145	2	IPR022164
Domain	Kinesin_assoc	KIF1A KIF1B	8.80e-04	6	145	2	IPR032405
Domain	DUF3694	KIF1A KIF1B	8.80e-04	6	145	2	PF12473
Domain	Spectrin_repeat	EVPL DST PLEC	1.44e-03	29	145	3	IPR002017
Domain	SPEC	EVPL DST PLEC	1.93e-03	32	145	3	SM00150
Domain	Spectrin/alpha-actinin	EVPL DST PLEC	1.93e-03	32	145	3	IPR018159
Domain	HEAT_REPEAT	NCAPD3 BTAF1 HEATR6 HTT	2.15e-03	70	145	4	PS50077
Domain	GPS	ADGRB1 ADGRL1 PKD1L2	2.50e-03	35	145	3	PF01825
Domain	GPS	ADGRB1 ADGRL1 PKD1L2	2.71e-03	36	145	3	PS50221
Domain	GAIN_dom_N	ADGRB1 ADGRL1	3.14e-03	11	145	2	IPR032471
Domain	PKD_channel	PKD1L2 PKDREJ	3.14e-03	11	145	2	PF08016
Domain	GAIN	ADGRB1 ADGRL1	3.14e-03	11	145	2	PF16489
Domain	PKD1_2_channel	PKD1L2 PKDREJ	3.14e-03	11	145	2	IPR013122
Domain	Myosin_head_motor_dom	MYO10 MYH7B MYO1B	3.17e-03	38	145	3	IPR001609
Domain	MYOSIN_MOTOR	MYO10 MYH7B MYO1B	3.17e-03	38	145	3	PS51456
Domain	Myosin_head	MYO10 MYH7B MYO1B	3.17e-03	38	145	3	PF00063
Domain	MYSc	MYO10 MYH7B MYO1B	3.17e-03	38	145	3	SM00242
Domain	IQ	MYO10 MYH7B MYO1B LRRIQ1	3.65e-03	81	145	4	SM00015
Domain	LDLR_class-A_CS	LRP1 LRP2 LRP6	3.67e-03	40	145	3	IPR023415
Domain	ABC_A	ABCA13 ABCA10	3.75e-03	12	145	2	IPR026082
Domain	APOBEC_N	APOBEC3G APOBEC3F	3.75e-03	12	145	2	PF08210
Domain	APOBEC_N	APOBEC3G APOBEC3F	3.75e-03	12	145	2	IPR013158
Domain	ABC_transporter_CS	ABCC9 ABCA10 ABCC12	4.22e-03	42	145	3	IPR017871
Domain	APOBEC/CMP_deaminase_Zn-bd	APOBEC3G APOBEC3F	5.12e-03	14	145	2	IPR016192
Domain	IQ_motif_EF-hand-BS	MYO10 MYH7B MYO1B LRRIQ1	5.32e-03	90	145	4	IPR000048
Domain	AAA	ABCA13 ABCC9 ABCA10 ABCC12 DYNC1H1	5.34e-03	144	145	5	SM00382
Domain	AAA+_ATPase	ABCA13 ABCC9 ABCA10 ABCC12 DYNC1H1	5.34e-03	144	145	5	IPR003593
Domain	CYT_DCMP_DEAMINASES_2	APOBEC3G APOBEC3F	5.88e-03	15	145	2	PS51747
Domain	IQ	MYO10 MYH7B MYO1B LRRIQ1	5.97e-03	93	145	4	PS50096
Domain	HEAT	NCAPD3 BTAF1 HTT	6.14e-03	48	145	3	PF02985
Domain	TBC	TBC1D5 TBC1D2 TBC1D13	6.50e-03	49	145	3	SM00164
Domain	CYT_DCMP_DEAMINASES_1	APOBEC3G APOBEC3F	7.54e-03	17	145	2	PS00903
Domain	CMP_dCMP_Zn-bd	APOBEC3G APOBEC3F	7.54e-03	17	145	2	IPR002125
Domain	Cytidine_deaminase-like	APOBEC3G APOBEC3F	7.54e-03	17	145	2	IPR016193
Domain	AMP-bd_C	ACSM2A ACSM2B	7.54e-03	17	145	2	IPR025110
Domain	AMP-binding_C	ACSM2A ACSM2B	7.54e-03	17	145	2	PF13193
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRPM4 MYO10 POLG NAGLU RAPGEF1 CUL9 ADGRL1 RNF40 BTAF1 MED13L ZZEF1 MAPK8IP3 C2CD2L GDPD5 DST AP2A1 PXN NLE1 POFUT1 PLEC ESPL1 DYNC1H1 HTT	3.88e-10	1105	149	23	35748872
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1B PKP4 HCN3 ADGRL1 CBARP SLC1A3 MAPK8IP3 C2CD2L DST AP2A1 TMEM163 PLEC HTT	3.84e-09	347	149	13	17114649
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	NCAPD3 COPA KIF1A HECTD3 GRAMD1A POR GALNT12 BTAF1 CLCC1 SPAG5 AP2A1 TVP23C LRP6 POFUT1 ESPL1 ANAPC5 RAB6A DYNC1H1	1.32e-07	942	149	18	31073040
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	COPA KIF1A POLG KIF1B CUL9 RNF40 MED13L MTMR10 MAPK8IP3 CRYL1 HEATR6 DST AP2A1 LRP1 LRP2 PLEC RAB6A DYNC1H1 BRWD1	2.72e-06	1285	149	19	35914814
Pubmed	A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.	COPA CUL9 ANAPC5 DYNC1H1	3.22e-06	24	149	4	33705438
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	TRPM4 NCAPD3 HECTD3 CUL9 ZZEF1 TRMT6 DST ZRANB1	3.98e-06	212	149	8	33853758
Pubmed	HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus.	KIF1A KIF1B DYNC1H1	4.25e-06	8	149	3	25818806
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CYP4V2 TRPM4 KIF1A APMAP TBC1D5 POLG KIF1B ADGRL1 BTAF1 XRCC2 RAB6B CLCC1 MAPK8IP3 TECPR2 TTLL11 LRP1 TVP23C PAN3 ZRANB1 HTT	6.13e-06	1489	149	20	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ASXL1 MYO10 KIF1B CUL9 ADGRL1 MED13L EPG5 C2CD2L KIAA0319 DYNC1H1	1.11e-05	407	149	10	12693553
Pubmed	LRP2 mediates folate uptake in the developing neural tube.	LRP1 LRP2 LRP6	1.24e-05	11	149	3	24639464
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ASXL1 COPA MYO10 TBC1D2 DST AP5Z1 PLEC NEURL1B DYNC1H1	1.43e-05	332	149	9	37433992
Pubmed	Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	17428847
Pubmed	Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	26482266
Pubmed	N-type Ca2+ channels are affected by full-length mutant huntingtin expression in a mouse model of Huntington's disease.	CACNA1B HTT	1.82e-05	2	149	2	28391067
Pubmed	Bpag1 localization to actin filaments and to the nucleus is regulated by its N-terminus.	DST PXN	1.82e-05	2	149	2	14576348
Pubmed	Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	19944180
Pubmed	Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	23318957
Pubmed	Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20299747
Pubmed	Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	17522216
Pubmed	Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	18619467
Pubmed	Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20610708
Pubmed	Interactions in vivo between the Vif protein of HIV-1 and the precursor (Pr55(GAG)) of the virion nucleocapsid proteins.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	19826902
Pubmed	The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	15647250
Pubmed	Atg4b-dependent autophagic flux alleviates Huntington's disease progression.	ATG4B HTT	1.82e-05	2	149	2	23861892
Pubmed	Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	16501124
Pubmed	The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors.	KIF1A KIF1B	1.82e-05	2	149	2	7539720
Pubmed	HIV-1 Vif: counteracting innate antiretroviral defenses.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	14565218
Pubmed	Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	18367521
Pubmed	Rab6-Mediated Polarized Transport of Synaptic Vesicle Precursors Is Essential for the Establishment of Neuronal Polarity and Brain Formation.	RAB6B RAB6A	1.82e-05	2	149	2	38830762
Pubmed	Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	19669862
Pubmed	Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	25590131
Pubmed	Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	19535447
Pubmed	Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3G.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	26048885
Pubmed	Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20624919
Pubmed	Comparative analyses of disease risk genes belonging to the acyl-CoA synthetase medium-chain (ACSM) family in human liver and cell lines.	ACSM2A ACSM2B	1.82e-05	2	149	2	19634011
Pubmed	ADRA2A polymorphisms and ADHD in adults: possible mediating effect of personality.	DRD5 ADRA2A	1.82e-05	2	149	2	20864182
Pubmed	RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	17609216
Pubmed	Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	19036809
Pubmed	Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	19587057
Pubmed	Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	17142455
Pubmed	A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	15152192
Pubmed	Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	25038404
Pubmed	Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	24185281
Pubmed	Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20335268
Pubmed	Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	24722422
Pubmed	Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20153011
Pubmed	Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	27881650
Pubmed	APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	17145955
Pubmed	Repression of porcine endogenous retrovirus infection by human APOBEC3 proteins.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	21396348
Pubmed	A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	15054139
Pubmed	Inhibition of hepatitis B virus replication by APOBEC3G.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	15031497
Pubmed	Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	24503066
Pubmed	Huntingtin recruits KIF1A to transport synaptic vesicle precursors along the mouse axon to support synaptic transmission and motor skill learning.	KIF1A HTT	1.82e-05	2	149	2	37431882
Pubmed	APOBEC3 proteins and reverse transcription.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	18262674
Pubmed	Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	24651717
Pubmed	Death and the retrovirus.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	14557052
Pubmed	Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20686027
Pubmed	The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population.	ACSM2A ACSM2B	1.82e-05	2	149	2	16521160
Pubmed	Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk.	LRP1 LRP6	1.82e-05	2	149	2	26031789
Pubmed	High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	25985400
Pubmed	Endocytic Protein Defects in the Neural Crest Cell Lineage and Its Pathway Are Associated with Congenital Heart Defects.	LRP1 LRP2	1.82e-05	2	149	2	34445520
Pubmed	APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	17121840
Pubmed	Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	24623435
Pubmed	E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	22695298
Pubmed	Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	19169351
Pubmed	APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20219927
Pubmed	Moderate influence of human APOBEC3F on HIV-1 replication in primary lymphocytes.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20592068
Pubmed	Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	17459442
Pubmed	Differential sensitivity of porcine endogenous retrovirus to APOBEC3-mediated inhibition.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	26016442
Pubmed	The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20844042
Pubmed	Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	25489169
Pubmed	Stably expressed APOBEC3F has negligible antiviral activity.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	20702622
Pubmed	Myosin-X knockout is semi-lethal and demonstrates that myosin-X functions in neural tube closure, pigmentation, hyaloid vasculature regression, and filopodia formation.	MYO10 TMEM163	1.82e-05	2	149	2	29229982
Pubmed	T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	23536679
Pubmed	Unusual substitutions in HIV-1 vif from children infected perinatally without progression to AIDS for more than 8 years without therapy.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	23080486
Pubmed	Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	19487726
Pubmed	APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	16641889
Pubmed	Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B.	ACSM2A ACSM2B	1.82e-05	2	149	2	29948332
Pubmed	Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	18448538
Pubmed	Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	21897871
Pubmed	APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	18604271
Pubmed	Identification of amino acid residues in HIV-1 Vif critical for binding and exclusion of APOBEC3G/F.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	18603011
Pubmed	Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	16940537
Pubmed	Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.	APOBEC3G APOBEC3F	1.82e-05	2	149	2	16460778
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NCAPD3 RNF40 ZZEF1 TRMT6 ATG4B DST TECPR2 AP5Z1 MED12L IGSF1 ESPL1	1.90e-05	529	149	11	14621295
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	NCAPD3 HECTD3 TBC1D5 PKP4 SENP3 BTAF1 ZZEF1 SYDE1 SPAG5 FREM2 DST ANAPC5	2.54e-05	650	149	12	38777146
Pubmed	Stage-specific association of apolipoprotein A-I and E in developing mouse retina.	LRP1 LRP2 LRP6	2.71e-05	14	149	3	17389516
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	COPA APMAP SENP3 MYO1B PSMD13 CLCC1 ATG4B AP2A1 AP5Z1 ANAPC5 DYNC1H1	3.19e-05	560	149	11	35241646
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	KIF1A MRS2 TBC1D5 PSMD13 ZRANB3 DST AP2A1 LRP2 PLEC ZRANB1	4.60e-05	481	149	10	28190767
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	COPA APMAP MYO1B PSMD13 ECI1 ZZEF1 SPAG5 EPG5 DST AP2A1 PLEC RAB6A DYNC1H1	4.75e-05	807	149	13	30575818
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	COPA SEC24A TBC1D5 PKP4 GRAMD1A NAGLU POR MYO1B CBARP PSMD13 MTMR10 CLCC1 PXN LRP6 FBXO33	4.79e-05	1049	149	15	27880917
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	FBXL13 MYO10 LRRIQ1 PLEC ESPL1 HTT	5.18e-05	152	149	6	34299191
Pubmed	The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.	APOBEC3G APOBEC3F	5.45e-05	3	149	2	22013041
Pubmed	Enhancing immunity to HIV through APOBEC.	APOBEC3G APOBEC3F	5.45e-05	3	149	2	18846074
Pubmed	Hematologically important mutations: leukocyte adhesion deficiency (first update).	SLC35C1 FERMT3	5.45e-05	3	149	2	22134107
Pubmed	BPAG1 isoform-b: complex distribution pattern in striated and heart muscle and association with plectin and alpha-actinin.	DST PLEC	5.45e-05	3	149	2	19932097
Pubmed	Rab6 family proteins interact with the dynein light chain protein DYNLRB1.	RAB6B RAB6A	5.45e-05	3	149	2	18044744
Pubmed	HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.	APOBEC3G APOBEC3F	5.45e-05	3	149	2	24942576
Pubmed	Accessories to the crime: recent advances in HIV accessory protein biology.	APOBEC3G APOBEC3F	5.45e-05	3	149	2	19149995
Pubmed	A kindlin-3-leupaxin-paxillin signaling pathway regulates podosome stability.	PXN FERMT3	5.45e-05	3	149	2	31537712
Interaction	STYK1 interactions	COPA SEC24A TBC1D5 GRAMD1A MYO1B CBARP CLCC1 DST DEPDC1B	3.01e-06	161	148	9	int:STYK1
Cytoband	20q11	ASXL1 POFUT1	1.56e-04	6	149	2	20q11
GeneFamily	EF-hand domain containing\|Plakins	EVPL DST PLEC	7.48e-06	8	94	3	939
GeneFamily	Low density lipoprotein receptors	LRP1 LRP2 LRP6	3.75e-05	13	94	3	634
GeneFamily	Cyclic nucleotide gated channels	HCN3 CNGA4	1.17e-03	10	94	2	250
GeneFamily	Apolipoprotein B mRNA editing enzyme catalytic subunits	APOBEC3G APOBEC3F	1.71e-03	12	94	2	406
GeneFamily	ATP binding cassette subfamily C	ABCC9 ABCC12	2.01e-03	13	94	2	807
GeneFamily	ATP binding cassette subfamily A	ABCA13 ABCA10	2.34e-03	14	94	2	805
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	KIF1A MYO10 KIF1B FERMT3 ADAP2	4.42e-03	206	94	5	682
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT12 GALNT13	4.78e-03	20	94	2	433
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	ZRANB3 ZRANB1	5.27e-03	21	94	2	89
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	TMPPE NPR2 POLG NAGLU POR NHLRC3 ZZEF1 MAPK8IP3 KATNBL1 LRP1 POFUT1 PAN3 HTT	2.26e-06	457	149	13	M1613
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	TMPPE NPR2 POLG NAGLU POR NHLRC3 ZZEF1 MAPK8IP3 KATNBL1 LRP1 POFUT1 PAN3 HTT	3.08e-06	470	149	13	MM1053
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CACNA1B ADGRL1 CBARP RAB6B C2CD2L CLVS2 TTLL11 RAB6A	3.06e-07	194	149	8	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A MYO10 KIF1B ADRA2A DST FAM151A TMEM163 DYNC1H1	3.18e-07	195	149	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B ABCA13 NDST4 MDGA2 FREM2 OTOGL ACSM2B	5.97e-07	145	149	7	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB1 ABCC9 MYO1B MDGA2 CLVS2 MED12L LRP6	1.02e-06	157	149	7	bfec34182f052cf1c0d847ba53ea335d4d1190de
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1B ABCA13 NDST4 MDGA2 FREM2 OTOGL ACSM2B	1.26e-06	162	149	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	KIF1A APOBEC3G ABCC9 NRROS ADRA2A GPR142 MED12L	1.37e-06	164	149	7	362c16ed7fb37bf16601fd5e059d3f3e2ed692b4
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNJL IL34 ABCC9 MYO1B MDGA2 CFAP54 ADAP2	1.95e-06	173	149	7	d78397e65e997ddb995111a810f0e2a4f67d0765
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNJL IL34 ABCC9 MYO1B MDGA2 CFAP54 ADAP2	1.95e-06	173	149	7	3c852ffe22f4a5b632463086b08c669310684e80
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP4V2 NDST4 GALNT12 MDGA2 GALNT13 SYTL5 LRRTM4	2.73e-06	182	149	7	eb4be1c02b8b033d025e57b8b4cdbfaec4698054
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 MDGA2 PKD1L2 GALNT13 FREM2 OTOGL LRP2	2.93e-06	184	149	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 MDGA2 PKD1L2 GALNT13 FREM2 OTOGL LRP2	2.93e-06	184	149	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 MDGA2 PKD1L2 GALNT13 FREM2 OTOGL LRP2	2.93e-06	184	149	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A PKP4 ADGRL1 ADRA2A DST FAM151A TMEM163	3.75e-06	191	149	7	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 ABCC9 GJB5 ADRA2A ASB10 DHRS7C ADAP2	4.16e-06	194	149	7	fb234d97191c95b7880280c6e4ed5df124ffb0e1
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A KIF1B ADRA2A DST FAM151A TMEM163 DYNC1H1	4.30e-06	195	149	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|343B / Donor, Lineage, Cell class and subclass (all cells)	NCAPD3 HCN3 XRCC2 SPAG5 ANGPT4 DEPDC1B	2.12e-05	167	149	6	7efa0081e79f22b219eac64ffcaedb2179cde299
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC1A3 GALNT13 FREM2 MMEL1 OTOGL LRP2	2.26e-05	169	149	6	0cece9b2bb1f58e465c20ec8735a4fc3c1021f03
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC1A3 GALNT13 FREM2 MMEL1 OTOGL LRP2	2.26e-05	169	149	6	6937c46b119d4ce382fc8c2fa5925ede5ae89c81
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL34 ADGRB1 OTOGL CLVS2 LRP1 NEURL1B	2.34e-05	170	149	6	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC35C1 PKP4 AP2A1 TECPR2 MED12L SLC49A3	2.50e-05	172	149	6	1bbf5ed7d13635f9a7e528060341e0652699bd7c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	POR CRYL1 OTOGL LRP2 ACSM2A ACSM2B	2.58e-05	173	149	6	8888434641ea554a9b62c436e87920378eef29cd
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPR2 SCD5 SPAG5 TVP23C ESPL1 DEPDC1B	2.67e-05	174	149	6	94575a605c725de83f66a6cf7df9d7bb360ffc56
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPR2 SCD5 SPAG5 TVP23C ESPL1 DEPDC1B	2.67e-05	174	149	6	40c81ab36d7931e271e20d7d56fed32463c75f41
ToppCell	facs-Heart-LV-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 TMPRSS9 HCN3 ABCC9 MYO1B ADAP2	2.67e-05	174	149	6	a0a059bb2a64d7011e206db2ebcdf3eb655a925a
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPR2 SCD5 SPAG5 TVP23C ESPL1 DEPDC1B	2.67e-05	174	149	6	b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4
ToppCell	facs-Heart-LV-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 TMPRSS9 HCN3 ABCC9 MYO1B ADAP2	2.67e-05	174	149	6	7cd6f9103133f8d7b90f9ff4b3b0b078cf554542
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CBARP FREM2 GJB5 FAM151A LRP2 CFAP57	2.67e-05	174	149	6	4da79da7a09ee1e345102c5331675ebcdbe56171
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FBXL13 MYO10 MYO1B SPNS3 MED12L TMEM163	2.94e-05	177	149	6	3a150dcaefa342d49968b42c7cdb1fbb633adcd0
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FBXL13 MYO10 MYO1B SPNS3 MED12L TMEM163	2.94e-05	177	149	6	c9e5820ff0bc7ad1adcfb2651713fdfc58bced56
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	POR CRYL1 FAM151A LRP2 ACSM2A ACSM2B	3.13e-05	179	149	6	78fae47ec9bff4e0159a86a281e831d7f8ee925a
ToppCell	facs-Limb_Muscle-Muscle_Diaphragm\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRTN3 SPNS3 NRROS SPAG5 LRP2 FERMT3	3.43e-05	182	149	6	81c394959414173016426961478f670cd822f8b3
ToppCell	facs-Limb_Muscle-Muscle_Diaphragm-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRTN3 SPNS3 NRROS SPAG5 LRP2 FERMT3	3.43e-05	182	149	6	41a7543c8b703441ff6ac2307faffe5f798b2c41
ToppCell	Control-T/NK_proliferative\|Control / Disease group and Cell class	NPR2 XRCC2 SPAG5 TVP23C ESPL1 DEPDC1B	3.54e-05	183	149	6	09c2b4e630f1c338f02c1242e3598e870d6b0a28
ToppCell	CF-Myeloid-Neutrophil\|CF / Disease state, Lineage and Cell class	FBXL13 TBC1D2 IL18RAP KIAA0319 KATNBL1 TECPR2	3.54e-05	183	149	6	da43827952e6fdee2ce94648c316182f272b321c
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYO10 USP43 MDGA2 SCD5 GALNT13 TMEM163	3.54e-05	183	149	6	8c8ce5a0d5535bef58ac10b7eb726f9c50af2ed8
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DRD5 MYH7B NDST4 XRCC2 LRRIQ1	3.92e-05	113	149	5	79ba2eb8f85e5da4c19c838df881c18ffdc450fb
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DRD5 MYH7B NDST4 XRCC2 LRRIQ1	3.92e-05	113	149	5	91d55fe6fb1c1472867d74461f5b9e4f17db01cd
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DRD5 MYH7B NDST4 XRCC2 LRRIQ1	3.92e-05	113	149	5	34ae3dec5ec7585d155ea61de6adc42aa4f45226
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 PKP4 USP43 MAPK8IP3 CFAP54 TMEM163	3.99e-05	187	149	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A PKP4 ADGRL1 ADRA2A DST FAM151A	4.11e-05	188	149	6	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 ABCC9 GJB5 LRRIQ1 DHRS7C ADAP2	4.11e-05	188	149	6	d534ed9870405a3c1075962308f72b460aed17bf
ToppCell	NS-critical-d_0-4-Lymphoid-NKT-proliferating\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCAPD3 XRCC2 SPAG5 TMEM163 ESPL1 DEPDC1B	4.23e-05	189	149	6	d6bd46abb072b13a6b72f1ca25d19f218cceb1ff
ToppCell	facs-Heart-LA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 ABCC9 MYO1B MDGA2 NALF2 ADAP2	4.49e-05	191	149	6	9c5d88f0d3c834c2419ec3da74652175153ba9df
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 ABCC9 MYO1B ADRA2A DHRS7C ADAP2	4.49e-05	191	149	6	f932980baa032748857cb367a55c37dd975c693e
ToppCell	facs-Heart-LA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 ABCC9 MYO1B MDGA2 NALF2 ADAP2	4.49e-05	191	149	6	a7494191a92984e5f53610bbbedd6714e9169e1c
ToppCell	human_hepatoblastoma-Tumor_cells-T8\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	POR MYO1B CRYL1 DST ACSM2A ACSM2B	4.62e-05	192	149	6	e785135262f4c9cc66c403bf362bb34643b212c5
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	TBC1D5 MED13L LRP2 PAN3 ACSM2A ACSM2B	4.62e-05	192	149	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 NCAPD3 ABCC9 MYO1B ADRA2A ADAP2	4.76e-05	193	149	6	b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA KIF1A KIF1B DST FAM151A ANAPC5	4.90e-05	194	149	6	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	USP43 FREM2 CFAP54 ADRA2A LRRIQ1 LRP2	4.90e-05	194	149	6	6b286992d4bb56013c0ea5a7601d3476d806175a
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TBC1D2 MYO1B SCD5 GALNT13 KIAA0319 DST	5.04e-05	195	149	6	a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL34 ABCC9 MYO1B SYDE1 NEURL1B ADAP2	5.33e-05	197	149	6	452be45f4aac8459dd860493171f5f715368d663
ToppCell	severe-Myeloid-Neutrophils_4\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	APMAP GRAMD1A KIF1B POR IL18RAP PXN	5.64e-05	199	149	6	50242666def13e5d4149c563ae000d6768f086f7
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	XRCC2 RAB6B CFAP54 MMEL1 ANAPC5 FERMT3	5.64e-05	199	149	6	b68648b4559e452656dc9e6a0974233e842f5e0d
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	XRCC2 SCD5 GALNT13 KIAA0319 NEURL1B DEPDC1B	5.64e-05	199	149	6	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SPNS3 KIAA0319 CFAP54 ADRA2A LRRIQ1 CFAP57	5.80e-05	200	149	6	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	Non-neuronal-Dividing-IPC\|World / Primary Cells by Cluster	MYO10 NEUROD4 XRCC2 SLC1A3 SPAG5 DEPDC1B	5.80e-05	200	149	6	971533181daa1bfac1f1b8c507d2013f891f9078
ToppCell	Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative\|URO / Disease, condition lineage and cell class	NCAPD3 CAPN14 FBXL13 XRCC2 ESPL1 DEPDC1B	5.80e-05	200	149	6	f277db6cc288a52a5426120c1067608700ee8ccc
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	ABCC9 MYO1B OTOGL CLVS2 LRP1 LRP6	5.80e-05	200	149	6	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	(18)_cycling_gd_T\|World / shred on Cell_type and subtype	CCNJL SAMD1 XRCC2 SPAG5 ESPL1 DEPDC1B	6.29e-05	203	149	6	7d58929058c4769226a29febee1fd8ba64bc9f1a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TMPRSS9 HTR5A KIF1A RNF40 DEPDC1B	9.13e-05	135	149	5	88f86bab637f1ca1439c7de2d12be4329cf662b8
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MDGA2 LRRTM4 LRP2 ACSM2A ACSM2B	1.05e-04	139	149	5	a1945b07f177cde40e7eea03a19236ce76165857
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB1 ABCC9 MDGA2 CLVS2 MED12L	1.80e-04	156	149	5	6365b69ede98bc866e996bc52736b00401aacf6f
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1B TMPRSS9 HECTD3 MIGA2 CFAP57	1.85e-04	157	149	5	4766f7d545bf2d775390589460677519cb92f4d5
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B GALNT13 LRRTM4 LRP2 ABCC12	2.02e-04	160	149	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B GALNT13 LRRTM4 LRP2 ABCC12	2.02e-04	160	149	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TMPRSS9 RAB6B SLC1A3 NEURL1B ESPL1	2.08e-04	161	149	5	8ec923c230a7a3cce5edf2a736b3a00d607c698a
ToppCell	343B-Epithelial_cells-Epithelial-H_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	XRCC2 SCD5 SLC1A3 GJB5 DST	2.08e-04	161	149	5	da9eecf919866a9c579d7a707a996cf335213134
ToppCell	343B-Epithelial_cells-Epithelial-H_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	XRCC2 SCD5 SLC1A3 GJB5 DST	2.08e-04	161	149	5	d431625c32f59a6b552191f3adc5198bd16ad5cf
ToppCell	15-Distal-Immune-Immune\|Distal / Age, Tissue, Lineage and Cell class	TMPPE IL18RAP ADRA2A MED12L FERMT3	2.14e-04	162	149	5	e190c496ed1e206b86566edfee23c99a99fe90d0
ToppCell	Bronchial-10x5prime-Stromal-Schwann\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IL34 KIF1A CLCC1 TTLL11 DEPDC1B	2.14e-04	162	149	5	afffecc6c504930554aafc12c5bffa53e3c5b016
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-3\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	CLCC1 APOBEC3F DST PXN DEPDC1B	2.20e-04	163	149	5	0e8d3c98209fc98b86b841d69051cee9e276d837
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	CACNA1B POR RAB6B FREM2 METTL24	2.27e-04	164	149	5	81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBXL13 USP43 GALNT12 TTLL11 TMEM163	2.54e-04	168	149	5	9e7b4b9b977e90e083f5164013e79df8bc2d492e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 USP43 CFAP54 LRRIQ1 CFAP57	2.61e-04	169	149	5	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	CTRL-Myeloid-Neutrophil\|CTRL / Disease state, Lineage and Cell class	CCNJL FBXL13 IL18RAP TECPR2 PXN	2.83e-04	172	149	5	ef3a6fe3b7300959f9f71130200c7fb8741c42b0
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KIF1A SLC35C1 RAPGEF1 CUL9 NRROS	2.83e-04	172	149	5	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid\|bone_marrow / Manually curated celltypes from each tissue	PRTN3 SPNS3 SLC1A3 SPAG5 DEPDC1B	2.90e-04	173	149	5	5645a3b1e805c71d5d65fc8e4edc4e13208063fc
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPD3 SCD5 SPAG5 TECPR2 NEURL1B	2.90e-04	173	149	5	20a20429aa898097d5ec4880ed64846558b5890f
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKP4 GALNT12 NHLRC3 FREM2 GJB5	2.98e-04	174	149	5	c58328c2f262506a4518f49f148e29874faf9171
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRTN3 SEC24A ABCC9 SPNS3 SLC49A3	2.98e-04	174	149	5	eb8012823b08729b462d1e5212f4873bb6b4eb1e
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	TBC1D2 MYO1B SCD5 GALNT13 DST	2.98e-04	174	149	5	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRTN3 SEC24A ABCC9 SPNS3 SLC49A3	2.98e-04	174	149	5	32fdeeebeeeca657eac6329caad4c28ca54e4d1c
ToppCell	CF-Myeloid-Neutrophil\|Myeloid / Disease state, Lineage and Cell class	FBXL13 IL18RAP KIAA0319 KATNBL1 TECPR2	3.06e-04	175	149	5	8020c3a34f77e68e8149f87481fb1dddd2ac675e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NCAPD3 XRCC2 NEURL1B ESPL1 DEPDC1B	3.06e-04	175	149	5	876cea684faf42ff3eb4623ad6d7a1fb1276ee02
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXL13 GALNT12 SPNS3 RAB6B TMEM163	3.14e-04	176	149	5	d4075796c38b775fe721abb47426e662a0d415e3
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SLC1A3 DST LRP1 ADAP2	3.22e-04	177	149	5	26bad614560609d318bfc9c235a698bca4e1c22c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST4 EVPL GALNT13 SYTL5 ABCC12	3.22e-04	177	149	5	1dc69c661e70e7e22bd9d7cf953eb638da9fd43c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST4 EVPL GALNT13 SYTL5 ABCC12	3.22e-04	177	149	5	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE-P1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CCNJL SYTL5 TMEM163 DEPDC1B	3.28e-04	98	149	4	fca0baf13520c53edb6da2fe3eb152fbd44df5ed
ToppCell	COVID-19-kidney-PCT-S1/S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CRYL1 FREM2 LRP2 ACSM2A ACSM2B	3.31e-04	178	149	5	23a12d3d971b857d5be8e907334d1f6b49eeeb32
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC9 SLC1A3 DST LRP1 ADAP2	3.31e-04	178	149	5	6c1b5087581ca8cea976d89ea6f34088c8fc3668
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 MYO1B ASB10 CFAP57 ADAP2	3.31e-04	178	149	5	7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 ABCC9 FREM2 NEURL1B ADAP2	3.31e-04	178	149	5	6bef4ef48f649c6e38ae732bc08e6d7814db588b
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MDGA2 CFAP54 LRP2 TMEM163 ACSM2A	3.31e-04	178	149	5	544379f5a6145429762258d426b876bb36c112f5
ToppCell	COVID-19_Mild-NK_CD56bright\|COVID-19_Mild / Disease condition and Cell class	CCNJL NHLRC3 IL18RAP DST SLC49A3	3.39e-04	179	149	5	90e7a4af195aa2332b07a9f06cde63e72ff49255
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 LRP2 TMEM163 ACSM2A ACSM2B	3.39e-04	179	149	5	58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CRYL1 OTOGL LRP2 ACSM2A ACSM2B	3.48e-04	180	149	5	f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e
ToppCell	droplet-Kidney-nan-18m-Epithelial-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 FAM151A CLVS2 LRP2 ACSM2B	3.48e-04	180	149	5	cd743f81838ba210e5bb63fe0870918d7d2b0112
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXL13 GALNT12 SPNS3 RAB6B TMEM163	3.48e-04	180	149	5	64f01494a4052186773720e10b4e7c724ff94547
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	TRPM4 COPA SLC35C1 POLG C2CD2L AP5Z1 PXN POFUT1 PLEC	6.14e-06	198	148	9	4979_DN
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; PC3; HT_HG-U133A	SEC24A SENP3 ADGRL1 MYO1B PSMD13 CLCC1 AP5Z1 POFUT1 BRWD1	6.66e-06	200	148	9	6284_DN
Drug	5-fluorocytidine	POLG APOBEC3G APOBEC3F PLEC	1.95e-05	25	148	4	CID000016861
Drug	CB1954	NPR2 POR APOBEC3G APOBEC3F	3.59e-05	29	148	4	CID000089105
Drug	monatepil	SAMD1 LRP1 LRP2 LRP6	3.59e-05	29	148	4	CID000060810
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A	SEC24A TBC1D5 POLG CUL9 CLCC1 NLE1 PLEC SLC25A28	3.95e-05	193	148	8	7097_UP
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	POR ADGRL1 TECPR2 PXN IGSF1 PLEC ANAPC5 BRWD1	4.10e-05	194	148	8	7406_DN
Drug	ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A	POLG ADGRL1 MYO1B BTN3A1 SYDE1 CRYL1 LRP6 HTT	4.10e-05	194	148	8	1146_UP
Drug	Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A	ABCC9 EVPL SCD5 MAPK8IP3 GDPD5 PXN POFUT1 ADAP2	4.10e-05	194	148	8	2825_UP
Drug	5-bromo-2-pyrimidinone	APOBEC3G APOBEC3F	4.20e-05	2	148	2	CID000101494
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A	COPA TBC1D5 ADGRL1 MYO1B MAPK8IP3 C2CD2L PXN LRP6	4.40e-05	196	148	8	1531_DN
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; HL60; HT_HG-U133A	ENTPD7 KIF1A SENP3 ADGRL1 ABCC9 BTN3A1 GDPD5 CRYL1	4.57e-05	197	148	8	2129_UP
Drug	SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A	TRPM4 ASXL1 SENP3 PXN POFUT1 SLC25A28 ADAP2 BRWD1	4.57e-05	197	148	8	6909_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A	ENTPD7 NPR2 TBC1D5 EVPL C2CD2L AP5Z1 LRP2 PXN	4.57e-05	197	148	8	4986_DN
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	SLC35C1 SEC24A POLG EVPL MYO1B GDPD5 LRP6 POFUT1	4.90e-05	199	148	8	7212_DN
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A	KIF1A TBC1D2 SYDE1 MAPK8IP3 CRYL1 LRP6 POFUT1 PLEC	4.90e-05	199	148	8	2402_DN
Drug	Mesalamine [89-57-6]; Up 200; 26.2uM; MCF7; HT_HG-U133A	TBC1D5 TBC1D2 CUL9 ZZEF1 RAB6B GDPD5 LRP6 POFUT1	5.08e-05	200	148	8	3584_UP
Disease	X-21319 measurement	ACSM2A ACSM2B	2.43e-05	2	146	2	EFO_0800807
Disease	X-11478 measurement	ACSM2A ACSM2B	7.27e-05	3	146	2	EFO_0021242
Disease	Leukocyte adhesion deficiency	SLC35C1 FERMT3	7.27e-05	3	146	2	cv:C0272187
Disease	DNA dC->dU-editing enzyme APOBEC-3G measurement	APOBEC3G APOBEC3F	7.27e-05	3	146	2	EFO_0802473
Disease	triclosan measurement, 8-hydroxydeoxyguanosine measurement	USP43 DHRS7C	1.45e-04	4	146	2	EFO_0801078, EFO_0801081
Disease	synucleinopathy (biomarker_via_orthology)	KIF1A KIF1B	1.45e-04	4	146	2	DOID:0050890 (biomarker_via_orthology)
Disease	Parkinson disease	CACNA1B TMPRSS9 TBC1D5 NAGLU MDGA2 HEATR6 MED12L TMEM163	2.07e-04	321	146	8	MONDO_0005180
Disease	dodecadienoate (12:2) measurement	ECI1 ACOT2	2.41e-04	5	146	2	EFO_0800572
Disease	3-hydroxyhexanoate measurement	ACSM2A ACSM2B	2.41e-04	5	146	2	EFO_0800378
Disease	indoleacetoylcarnitine measurement	ACSM2A ACSM2B	3.60e-04	6	146	2	EFO_0800106
Disease	epidermolysis bullosa simplex (is_implicated_in)	DST PLEC	5.02e-04	7	146	2	DOID:4644 (is_implicated_in)
Disease	octadecanedioylcarnitine (C18-DC) measurement	CYP4V2 ACOT2	5.02e-04	7	146	2	EFO_0800371
Disease	hereditary spastic paraplegia (is_implicated_in)	KIF1A AP5Z1	5.02e-04	7	146	2	DOID:2476 (is_implicated_in)
Disease	age at first sexual intercourse measurement	TBC1D5 MDGA2 TTLL11 POFUT1 FBXO33 IGSF1 DEPDC1B BRWD1	6.67e-04	383	146	8	EFO_0009749
Disease	age at initiation of corrective lens use	TBC1D5 BRWD1	6.68e-04	8	146	2	EFO_0021781
Disease	Immature Reticulocyte Fraction Measurement	S1PR2 FERMT3	1.07e-03	10	146	2	EFO_0009253
Disease	response to simvastatin, myopathy	ABCA13 SPNS3 CLVS2	1.10e-03	41	146	3	EFO_0004145, GO_1903491
Disease	cortical thickness	IL34 NPR2 FBXL13 TBC1D5 CUL9 ABCC9 GALNT12 SPNS3 MAPK8IP3 LRRIQ1 ANGPT4 LRP1 CFAP57 PLEC	1.29e-03	1113	146	14	EFO_0004840
Disease	urinary uromodulin measurement	LRRTM4 ACSM2A DYNC1H1 ACSM2B	1.34e-03	96	146	4	EFO_0005663
Disease	nervous system disease (implicated_via_orthology)	KIF1A KIF1B	1.55e-03	12	146	2	DOID:863 (implicated_via_orthology)
Disease	Intellectual Disability	CACNA1B NAGLU MED13L MAPK8IP3 MED12L LRP2 DYNC1H1 HTT	1.78e-03	447	146	8	C3714756
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH7B SCD5	1.83e-03	13	146	2	DOID:397 (implicated_via_orthology)
Disease	glycochenodeoxycholate glucuronide (1) measurement	ENTPD7 SLC25A28	1.83e-03	13	146	2	EFO_0800474
Disease	Proteinuria	CRYL1 LRP2	2.45e-03	15	146	2	HP_0000093
Disease	myelodysplastic syndrome (implicated_via_orthology)	ASXL1 POLG	2.45e-03	15	146	2	DOID:0050908 (implicated_via_orthology)
Disease	gout	ABCC9 DST ASB10 LRP2 ACSM2B	2.98e-03	196	146	5	EFO_0004274
Disease	Charcot-Marie-Tooth disease type 2	KIF1B DYNC1H1	3.15e-03	17	146	2	cv:C0270914
Disease	fibroblast growth factor basic measurement	NHLRC3 CLCC1 METTL24	3.15e-03	59	146	3	EFO_0008130
Disease	attention deficit hyperactivity disorder (is_implicated_in)	DRD5 ADRA2A	4.36e-03	20	146	2	DOID:1094 (is_implicated_in)
Disease	eye colour measurement	GALNT12 MDGA2 LRRTM4 LRP2 ZRANB1	4.67e-03	218	146	5	EFO_0009764

Protein segments in the cluster

Peptide	Gene	Start	Entry
QVLNTLWQYRDLRSI	PKP4	986	Q99569
QTSYRDLWSLRASLE	CBARP	431	Q8N350
EIAVIRDWLLNYNLT	EPG5	871	Q9HCE0
RYWAQLDETVEALLR	RNF40	96	O75150
ITKILRSWREYDLAV	CFAP54	1211	Q96N23
LWRRQIYAVATLRFL	ABCA10	751	Q8WWZ4
VKLLEELRWRSIQYA	BTN3A1	306	O00481
SVWRYIRSERSVILI	ADGRB1	971	O14514
FYNRPILSRRNTVWL	APOBEC3G	21	Q9HC16
YQGRINELLLSVITW	ADGRL1	851	O94910
RTLYINSRQLVSLQW	ACSM2A	21	Q08AH3
NIRALRLWSLTYEEE	ASB10	101	Q8WXI3
LQLSPYWTRDLQRIS	CCNJL	266	Q8IV13
WYVDTILNLIRIAGD	AP2A1	441	O95782
QSNWRYFTELILRPI	ABCA13	1516	Q86UQ4
AVLRASRLYQWSLKS	ACOT2	26	P49753
YRATRLWNETVELFR	DEPDC1B	11	Q8WUY9
FLSAANRWLEVRTDY	ABCC9	1211	O60706
DSSSKWQRRDYLLLV	APMAP	216	Q9HDC9
NWTARAALLYLDART	NPR2	161	P20594
LSKRLVDWLRYASLQ	AP5Z1	176	O43299
YWSSLRNLVVSLLNS	CACNA1B	591	Q00975
NVLLFYRLWSLERTA	GRAMD1A	626	Q96CP6
RTWAEAARLVLENYS	ASXL1	11	Q8IXJ9
EILSDVASRLWFTYR	ATG4B	41	Q9Y4P1
IVDWFNALRAARLQY	ADAP2	221	Q9NPF8
LWDILIEATYNRTLI	CAPN14	221	A8MX76
YNRSDVFEAWRLLLT	NAGLU	531	P54802
YLEDRTVRLQLWDTA	RAB6A	56	P20340
YLEDRTVRLQLWDTA	RAB6B	56	Q9NRW1
ASILNLCVISVDRYW	DRD5	126	P21918
ISVLLSVAELYWRSS	ANAPC5	581	Q9UJX4
AASALLYRHWIEIVL	IL18RAP	376	O95256
FWRKRSISELVAYLL	KATNBL1	171	Q9H079
EWTQISTRYLREQLA	MED12L	186	Q86YW9
LRFVLEQYNALSWLT	MED13L	2166	Q71F56
VWVSIRLDSTLRLYH	MAPK8IP3	1101	Q9UPT6
LRSIYLQWNRIRSIS	LRRTM4	231	Q86VH4
YLSWVVEARRHILAI	POR	416	P16435
RTAQLVYDREVQWTL	ENTPD7	501	Q9NQZ7
LSSLENTRWLEYVRA	MTMR10	366	Q9NXD2
VVSWHYLINEIDRIR	DST	976	Q03001
YRDSVLTWLLRENLG	KIF1B	306	O60333
KRILWIDARSDAIYS	LRP1	1446	Q07954
RSIRLWNYETNTLEL	CFAP57	411	Q96MR6
INDTLTRYRWLISAP	FREM2	2426	Q5SZK8
AVLVLQVWDYDRISA	FER1L4	1586	A9Z1Z3
ALQLSARWLEVLRTY	FBXO33	171	Q7Z6M2
TYDRLFRWLVSRINQ	MYH7B	476	A7E2Y1
TIRSQYRDLLKAASW	EVPL	206	Q92817
IQYLELDRLVWRNSI	FBXO39	131	Q8N4B4
QRLVEERYSWTSQLS	POLG	226	P54098
VDQYARIWNALVTAL	HEATR6	1036	Q6AI08
YRNVLEALWRIIRTE	SLC25A28	111	Q96A46
FRAIEALLQYWINTL	MRS2	186	Q9HD23
RLYTKLLNEATRWSS	MYO10	1476	Q9HD67
AKRRLYWTDLDTNLI	LRP6	801	O75581
SVLAVLRNRWLSDSF	MIGA2	451	Q7L4E1
VSRQELRDYASWNLS	GDPD5	436	Q8WTR4
QRWRLSLASLLFFTV	NALF2	41	O75949
YWVDASLQRIERSTL	LRP2	2566	P98164
RNTDRQWLIDTLYAF	PSMD13	226	Q9UNM6
IERWLTYFATSQLLI	NDST4	751	Q9H3R1
VALYVDWIRSTLRRV	PRTN3	236	P24158
TRYLRTWFLVDLISS	HCN3	166	Q9P1Z3
SARTIQNYLVWRLVL	MMEL1	391	Q495T6
ESTLLYSIEERRLAW	LRRIQ1	731	Q96JM4
VLTYEWRLGNKLLRT	MDGA2	571	Q7Z553
SRILRYLFDNTWLDA	PKD1L2	2116	Q7Z442
EAWSTLLRTVYSVIN	GALNT13	126	Q8IUC8
RAILENYISALNTLW	PXN	481	P49023
LIWAYIVQLSSALRT	PAN3	616	Q58A45
LRALQIALVVSLYWV	SLC35C1	36	Q96A29
LWLRLYQSNLVLVSA	ECI1	131	P42126
FYNRPILSRRNTVWL	APOBEC3F	21	Q8IUX4
AWYLLRVQVLQLVAA	ESPL1	896	Q14674
IDVLTLRNSSYWLVR	HTT	851	P42858
LRNSSYWLVRTELLE	HTT	856	P42858
SERELRYLWVLVSLS	IL34	86	Q6ZMJ4
LTWNYVLNEAIRLSL	IGSF1	511	Q8N6C5
KVLIYLRSANWDTRI	BTAF1	46	O14981
ASLLTVFAWLLQYAR	C2CD2L	21	O14523
LLSQSERYSLTLWQA	FAM151A	261	Q8WW52
LTAVWVARNRFAVLD	COPA	416	P53621
VDWFLDRLRTTTNVL	SLC1A3	471	P43003
NEAWSTLLRTVYSVL	GALNT12	146	Q8IXK2
TASIWNVTAIALDRY	HTR5A	126	P47898
NVTAIALDRYWSITR	HTR5A	131	P47898
TRRAAYSLRVELQDW	ANGPT4	371	Q9Y264
LSLLQRVASYARKWQ	CYP4V2	31	Q6ZWL3
YIVSTLQRWRLNVLR	FBXL13	211	Q8NEE6
RLSALVWEVRYIEHN	BRWD1	1221	Q9NSI6
VWIAILLTVDRYTAL	GPR142	246	Q7Z601
SFWLNLERALYRIQE	DYNC1H1	276	Q14204
LFYTIRAQAWSRDIA	CUL9	1316	Q8IWT3
VYSRIEQLLTSDWAV	CXorf38	201	Q8TB03
NRLQYAIISEAWRLV	CRYL1	196	Q9Y2S2
WERLENLYDALISVA	DHRS7C	71	A6NNS2
FRVLVYLVTAERVWS	GJB5	31	O95377
YQEWILDTIDSLRSR	SAMD1	31	Q6SPF0
SLLNPVIYTWRSRDL	S1PR2	281	O95136
YRDSVLTWLLRENLG	KIF1A	306	Q12756
TRLRVLNVSYNVLEW	NRROS	226	Q86YC3
VWDLAQQVVLSSYRA	WDR77	151	Q9BQA1
RIYIQLTSAWKRRTL	OTOGL	601	Q3ZCN5
LWVRSLDAQSVYVAT	POFUT1	296	Q9H488
EEAWRFLRYISTTQI	METTL24	126	Q5JXM2
AYLQSLEPSSRRWVL	SYDE1	71	Q6ZW31
LETRTLQLSVWHYDR	SYTL5	486	Q8TDW5
AVYQIAWSADSRLLV	NLE1	416	Q9NVX2
DYTTWTALLSRSRQL	SPAG5	651	Q96R06
ESARIIAFISWLREQ	SEC24A	1031	O95486
LATVTKLEDIYRWLN	PKDREJ	1751	Q9NTG1
LRYTISLNISWLVNS	SCD5	226	Q86SK9
ALAWAINYRTAIRLK	ABCC12	181	Q96J65
AISLDRYWSITQAIE	ADRA2A	141	P08913
RTLYINSRQLVSLQW	ACSM2B	21	Q68CK6
RLDYSRIIQSWEKIS	NCAPD3	731	P42695
YVRWYTQLRRVLIIS	CLCC1	206	Q96S66
SALKIAYRIERLEWQ	CNGA4	521	Q8IV77
WDQSRYTLVDILRAI	CLVS2	126	Q5SYC1
YARRWVFLLAISLLN	SLC49A3	26	Q6UXD7
WSLISVDVRRRTITY	SENP3	466	Q9H4L4
AVDILYIDITRRWNS	TTLL11	681	Q8NHH1
QLAALVRALWTREYT	USP43	146	Q70EL4
DINSFTRITDRALYW	TVP23C	201	Q96ET8
ELIRDTRWDIQSYTT	XKRY	141	O14609
AVSWRTEKILYRLDV	NHLRC3	36	Q5JS37
LTALYLERDETRAWQ	SPNS3	466	Q6ZMD2
SRVYQSLANLIRWSD	RAPGEF1	156	Q13905
NLALRDTVLAYWADR	NEURL1B	136	A8MQ27
YARVTRLRDWILEAT	TMPRSS9	421	Q7Z410
RASWTSILAKQRELY	TBC1D13	56	Q9NVG8
VRLTQLYEQARWDLL	FERMT3	266	Q86UX7
VVWALTEQRALLYRE	TECPR2	946	O15040
DSTLRYLQDLLAWVE	PLEC	656	Q15149
LALNIWVTVTVLRYR	SLC66A3	181	Q8N755
LILDSLSAFYWIDRV	XRCC2	146	O43543
INLRLSETWLRNYQV	TRMT6	421	Q9UJA5
VLYARHVLASLLAEW	ZZEF1	2616	O43149
ISRIEELRAWYSNIK	TBC1D5	106	Q92609
ILDVLSSAIVLWRYS	TMEM163	126	Q8TC26
SAYLDELRLAVAWNR	TRPM4	391	Q8TD43
SLSQRLRLYLADSWN	TRPM4	851	Q8TD43
TRLDSRLYALWNRTA	ZRANB1	426	Q9UGI0
LISNILLRVWDAFLY	TBC1D2	801	Q9BYX2
YRSLILRFVREWSSL	ZRANB3	781	Q5FWF4
ASRSYLAESLELRAW	TMPPE	26	Q6ZT21
LRWEQVVDLTYSHRL	HECTD3	176	Q5T447
SRSTDDQRIVSYLWI	KIAA0319	741	Q5VV43
LYSRLFSWLVNRINE	MYO1B	356	O43795
IETLRLARNYIWALS	NEUROD4	126	Q9HD90
LARNYIWALSEVLET	NEUROD4	131	Q9HD90